Adam M Brufsky (Adam Brufsky)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 77

Top Topics

African American

Metastatic Breast Cancer

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

NPJ breast cancer

Journal of medical virology

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Charles E Geyer, Joanne L Blum, Greg Yothers, Lina Asmar, Patrick J Flynn, Nicholas J Robert, Judith O Hopkins, Joyce A O'Shaughnessy, Priya Rastogi, Shannon L Puhalla, Christie J Hilton, Chau T Dang, Henry Leonidas Gómez, Svetislava J Vukelja, Alan P Lyss, Devchand Paul, Adam M Brufsky, Linda H Colangelo, Sandra M Swain, Eleftherios P P Mamounas, Norman Wolmark
Long-Term Follow-Up of the Anthracyclines in Early Breast Cancer Trials (USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 [NRG Oncology]). Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Margarita L Zuley, Jonathan C Silverstein, Durwin Logue, Richard S Morgan, Rohit Bhargava, Priscilla F McAuliffe, Adam M Brufsky, Andriy I Bandos, Robert M Nishikawa
Organizational Breast Cancer Data Mart: A Solution for Assessing Outcomes of Imaging and Treatment. JCO clinical cancer informatics 8 (2024)
Margarita L Zuley, Jonathan C Silverstein, Durwin Logue, Richard S Morgan, Rohit Bhargava, Priscilla F McAuliffe, Adam M Brufsky, Andriy I Bandos, Robert M Nishikawa
Organizational Breast Cancer Data Mart: A Solution for Assessing Outcomes of Imaging and Treatment. JCO clinical cancer informatics 8 (2024)
Aditya Bardia, Hope S Rugo, Sara M Tolaney, Delphine Loirat, Kevin Punie, Mafalda Oliveira, Adam M Brufsky, Kevin M Kalinsky, Javier Cortes, Joyce O' Shaughnessy, Véronique Diéras, Lisa Anne Carey, Luca Gianni, Martine J Piccart, Sibylle Loibl, Oh Kyu Yoon, Yang Pan, Scott Hofsess, See-Chun Phan, Sara Alsterlind Hurvitz
Final Results From the Randomized Phase III ASCENT Clinical Trial in Metastatic Triple-Negative Breast Cancer and Association of Outcomes by Human Epidermal Growth Factor Receptor 2 and Trophoblast Cell Surface Antigen 2 Expression. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (15) (2024)
Azadeh Nasrazadani, Juan Luis Gomez Marti, Kate Lathrop, Alvaro Restrepo, Szu-Yun Leu, Gajanan Bhat, Adam M Brufsky
Poziotinib treatment in patients with HER2-positive advanced breast cancer who have received prior anti-HER2 regimens. Breast cancer research and treatment (2024)
Charles E Geyer, Joanne L Blum, Greg Yothers, Lina Asmar, Patrick J Flynn, Nicholas J Robert, Judith O Hopkins, Joyce A O'Shaughnessy, Priya Rastogi, Shannon L Puhalla, Christie J Hilton, Chau T Dang, Henry Leonidas Gómez, Svetislava J Vukelja, Alan P Lyss, Devchand Paul, Adam M Brufsky, Linda H Colangelo, Sandra M Swain, Eleftherios P P Mamounas, Norman Wolmark
Long-Term Follow-Up of the Anthracyclines in Early Breast Cancer Trials (USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 [NRG Oncology]). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (12) (2024)
Priya Rastogi, Hanna Bandos, Peter C Lucas, Laura van 't Veer, Jia-Perng J Wei, Charles E Geyer, Louis Fehrenbacher, Stephen K L Chia, Adam M Brufsky, Janice M Walshe, Gamini S Soori, Shaker R Dakhil, Soonmyung Paik, Sandra M Swain, Andrea R Menicucci, M William Audeh, Norman Wolmark, Eleftherios P P Mamounas
Utility of the 70-Gene MammaPrint Assay for Prediction of Benefit From Extended Letrozole Therapy in the NRG Oncology/NSABP B-42 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Charles E Geyer, Joanne L Blum, Greg Yothers, Lina Asmar, Patrick J Flynn, Nicholas J Robert, Judith O Hopkins, Joyce A O'Shaughnessy, Priya Rastogi, Shannon L Puhalla, Christie J Hilton, Chau T Dang, Henry Leonidas Gómez, Svetislava J Vukelja, Alan P Lyss, Devchand Paul, Adam M Brufsky, Linda H Colangelo, Sandra M Swain, Eleftherios P P Mamounas, Norman Wolmark
Long-Term Follow-Up of the Anthracyclines in Early Breast Cancer Trials (USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 [NRG Oncology]). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (12) (2024)
Charles E Geyer, Joanne L Blum, Greg Yothers, Lina Asmar, Patrick J Flynn, Nicholas J Robert, Judith O Hopkins, Joyce A O'Shaughnessy, Priya Rastogi, Shannon L Puhalla, Christie J Hilton, Chau T Dang, Henry Leonidas Gómez, Svetislava J Vukelja, Alan P Lyss, Devchand Paul, Adam M Brufsky, Linda H Colangelo, Sandra M Swain, Eleftherios P P Mamounas, Norman Wolmark
Long-Term Follow-Up of the Anthracyclines in Early Breast Cancer Trials (USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 [NRG Oncology]). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (12) (2024)
Margarita L Zuley, Andriy I Bandos, Stephen W Duffy, Durwin Logue, Rohit Bhargava, Priscilla F McAuliffe, Adam M Brufsky, Robert M Nishikawa
Breast Cancer Screening Interval: Effect on Rate of Late-Stage Disease at Diagnosis and Overall Survival. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Eleftherios P P Mamounas, Hanna Bandos, Priya Rastogi, Yi Zhang, Kai Treuner, Peter C Lucas, Charles E Geyer, Louis Fehrenbacher, Stephen K L Chia, Adam M Brufsky, Janice M Walshe, Gamini S Soori, Shaker R Dakhil, Soonmyung Paik, Sandra M Swain, Dennis C Sgroi, Catherine A Schnabel, Norman Wolmark
Breast Cancer Index and Prediction of Extended Aromatase Inhibitor Therapy Benefit in Hormone Receptor-positive Breast Cancer from the NRG Oncology/NSABP B-42 Trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Aditya Bardia, Hope S Rugo, Sara M Tolaney, Delphine Loirat, Kevin Punie, Mafalda Oliveira, Adam M Brufsky, Kevin M Kalinsky, Javier Cortes, Joyce O' Shaughnessy, Véronique Diéras, Lisa Anne Carey, Luca Gianni, Martine J Piccart, Sibylle Loibl, Oh Kyu Yoon, Yang Pan, Scott Hofsess, See-Chun Phan, Sara Alsterlind Hurvitz
Final Results From the Randomized Phase III ASCENT Clinical Trial in Metastatic Triple-Negative Breast Cancer and Association of Outcomes by Human Epidermal Growth Factor Receptor 2 and Trophoblast Cell Surface Antigen 2 Expression. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (15) (2024)
Evanthia T Roussos Torres, Won Jin Ho, Ludmila Danilova, Joseph A Tandurella, James Leatherman, Christine Rafie, Chenguang Wang, Adam M Brufsky, Patricia M LoRusso, Vincent Chung, Yuan Yuan, Melinda Downs, Ashley O'Connor, Sarah M Shin, Alexei Hernandez, Elizabeth L Engle, Richard Piekarz, Howard Streicher, Zahra Talebi, Michelle A Rudek, Qingfeng Zhu, Robert A Anders, Ashley Cimino-Mathews, Elana J Fertig, Elizabeth D Thompson, Vered Stearns, Caitriona Cahir
Entinostat, nivolumab and ipilimumab for women with advanced HER2-negative breast cancer: a phase Ib trial. Nature cancer 5 (6) (2024)
Adam M Brufsky, Marilyn L Kwan, Rickard Sandin, Stella Stergiopoulos, Siddharth Karanth, Ashley S Cha-Silva, Doris Makari, Ravi K Goyal
Trends in HR+ metastatic breast cancer survival before and after CDK4/6 inhibitor introduction in the United States: a SEER registry analysis of patients with HER2- and HER2+ metastatic breast cancer. Breast cancer research and treatment (2024)
Eleftherios P P Mamounas, Hanna Bandos, Priya Rastogi, Yi Zhang, Kai Treuner, Peter C Lucas, Charles E Geyer, Louis Fehrenbacher, Stephen K L Chia, Adam M Brufsky, Janice M Walshe, Gamini S Soori, Shaker R Dakhil, Soonmyung Paik, Sandra M Swain, Dennis C Sgroi, Catherine A Schnabel, Norman Wolmark
Breast Cancer Index and Prediction of Extended Aromatase Inhibitor Therapy Benefit in Hormone Receptor-Positive Breast Cancer from the NRG Oncology/NSABP B-42 Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (9) (2024)
Priya Rastogi, Hanna Bandos, Peter C Lucas, Laura van 't Veer, Jia-Perng J Wei, Charles E Geyer, Louis Fehrenbacher, Stephen K L Chia, Adam M Brufsky, Janice M Walshe, Gamini S Soori, Shaker R Dakhil, Soonmyung Paik, Sandra M Swain, Andrea R Menicucci, M William Audeh, Norman Wolmark, Eleftherios P P Mamounas
Utility of the 70-Gene MammaPrint Assay for Prediction of Benefit From Extended Letrozole Therapy in the NRG Oncology/NSABP B-42 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Adam M Brufsky, Martine C Maculaitis, Lewis Kopenhafer, Patrick Olsen, Samantha K Kurosky, Lillian Shahied Arruda, Wendy Heck, Ashley S Cha-Silva
Identifying drivers of first-line HR+/HER2- metastatic breast cancer treatment choices. Future oncology (London, England) (2024)
Evanthia T Roussos Torres, Won Jin Ho, Ludmila Danilova, Joseph A Tandurella, James Leatherman, Christine Rafie, Chenguang Wang, Adam M Brufsky, Patricia M LoRusso, Vincent Chung, Yuan Yuan, Melinda Downs, Ashley O'Connor, Sarah M Shin, Alexei Hernandez, Elizabeth L Engle, Richard Piekarz, Howard Streicher, Zahra Talebi, Michelle A Rudek, Qingfeng Zhu, Robert A Anders, Ashley Cimino-Mathews, Elana J Fertig, Elizabeth D Thompson, Vered Stearns, Caitriona Cahir
Entinostat, nivolumab and ipilimumab for women with advanced HER2-negative breast cancer: a phase Ib trial. Nature cancer 5 (6) (2024)
Aditya Bardia, Hope S Rugo, Sara M Tolaney, Delphine Loirat, Kevin Punie, Mafalda Oliveira, Adam M Brufsky, Kevin M Kalinsky, Javier Cortes, Joyce O' Shaughnessy, Véronique Diéras, Lisa Anne Carey, Luca Gianni, Martine J Piccart, Sibylle Loibl, Oh Kyu Yoon, Yang Pan, Scott Hofsess, See-Chun Phan, Sara Alsterlind Hurvitz
Final Results From the Randomized Phase III ASCENT Clinical Trial in Metastatic Triple-Negative Breast Cancer and Association of Outcomes by Human Epidermal Growth Factor Receptor 2 and Trophoblast Cell Surface Antigen 2 Expression. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Charles E Geyer, Joanne L Blum, Greg Yothers, Lina Asmar, Patrick J Flynn, Nicholas J Robert, Judith O Hopkins, Joyce A O'Shaughnessy, Priya Rastogi, Shannon L Puhalla, Christie J Hilton, Chau T Dang, Henry Leonidas Gómez, Svetislava J Vukelja, Alan P Lyss, Devchand Paul, Adam M Brufsky, Linda H Colangelo, Sandra M Swain, Eleftherios P P Mamounas, Norman Wolmark
Long-Term Follow-Up of the Anthracyclines in Early Breast Cancer Trials (USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 [NRG Oncology]). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (12) (2024)
Azadeh Nasrazadani, Juan Luis Gomez Marti, Kate Lathrop, Alvaro Restrepo, Szu-Yun Leu, Gajanan Bhat, Adam M Brufsky
Poziotinib treatment in patients with HER2-positive advanced breast cancer who have received prior anti-HER2 regimens. Breast cancer research and treatment 205 (1) (2024)
Charles E Geyer, Joanne L Blum, Greg Yothers, Lina Asmar, Patrick J Flynn, Nicholas J Robert, Judith O Hopkins, Joyce A O'Shaughnessy, Priya Rastogi, Shannon L Puhalla, Christie J Hilton, Chau T Dang, Henry Leonidas Gómez, Svetislava J Vukelja, Alan P Lyss, Devchand Paul, Adam M Brufsky, Linda H Colangelo, Sandra M Swain, Eleftherios P P Mamounas, Norman Wolmark
Long-Term Follow-Up of the Anthracyclines in Early Breast Cancer Trials (USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 [NRG Oncology]). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (12) (2024)
Azadeh Nasrazadani, Juan Luis Gomez Marti, Kate Lathrop, Alvaro Restrepo, Szu-Yun Leu, Gajanan Bhat, Adam M Brufsky
Poziotinib treatment in patients with HER2-positive advanced breast cancer who have received prior anti-HER2 regimens. Breast cancer research and treatment 205 (1) (2024)
Priya Rastogi, Hanna Bandos, Peter C Lucas, Laura van 't Veer, Jia-Perng J Wei, Charles E Geyer, Louis Fehrenbacher, Stephen K L Chia, Adam M Brufsky, Janice M Walshe, Gamini S Soori, Shaker R Dakhil, Soonmyung Paik, Sandra M Swain, Andrea R Menicucci, M William Audeh, Norman Wolmark, Eleftherios P P Mamounas
Utility of the 70-Gene MammaPrint Assay for Prediction of Benefit From Extended Letrozole Therapy in the NRG Oncology/NSABP B-42 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Evanthia T Roussos Torres, Won Jin Ho, Ludmila Danilova, Joseph A Tandurella, James Leatherman, Christine Rafie, Chenguang Wang, Adam M Brufsky, Patricia M LoRusso, Vincent Chung, Yuan Yuan, Melinda Downs, Ashley O'Connor, Sarah M Shin, Alexei Hernandez, Elizabeth L Engle, Richard Piekarz, Howard Streicher, Zahra Talebi, Michelle A Rudek, Qingfeng Zhu, Robert A Anders, Ashley Cimino-Mathews, Elana J Fertig, Elizabeth D Thompson, Vered Stearns, Caitriona Cahir
Entinostat, nivolumab and ipilimumab for women with advanced HER2-negative breast cancer: a phase Ib trial. Nature cancer 5 (6) (2024)
Azadeh Nasrazadani, Juan Luis Gomez Marti, Kate Lathrop, Alvaro Restrepo, Szu-Yun Leu, Gajanan Bhat, Adam M Brufsky
Poziotinib treatment in patients with HER2-positive advanced breast cancer who have received prior anti-HER2 regimens. Breast cancer research and treatment 205 (1) (2024)
Eleftherios P P Mamounas, Hanna Bandos, Priya Rastogi, Yi Zhang, Kai Treuner, Peter C Lucas, Charles E Geyer, Louis Fehrenbacher, Stephen K L Chia, Adam M Brufsky, Janice M Walshe, Gamini S Soori, Shaker R Dakhil, Soonmyung Paik, Sandra M Swain, Dennis C Sgroi, Catherine A Schnabel, Norman Wolmark
Breast Cancer Index and Prediction of Extended Aromatase Inhibitor Therapy Benefit in Hormone Receptor-Positive Breast Cancer from the NRG Oncology/NSABP B-42 Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (9) (2024)
Eleftherios P P Mamounas, Hanna Bandos, Priya Rastogi, Yi Zhang, Kai Treuner, Peter C Lucas, Charles E Geyer, Louis Fehrenbacher, Stephen K L Chia, Adam M Brufsky, Janice M Walshe, Gamini S Soori, Shaker R Dakhil, Soonmyung Paik, Sandra M Swain, Dennis C Sgroi, Catherine A Schnabel, Norman Wolmark
Breast Cancer Index and Prediction of Extended Aromatase Inhibitor Therapy Benefit in Hormone Receptor-positive Breast Cancer from the NRG Oncology/NSABP B-42 Trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Charles E Geyer, Joanne L Blum, Greg Yothers, Lina Asmar, Patrick J Flynn, Nicholas J Robert, Judith O Hopkins, Joyce A O'Shaughnessy, Priya Rastogi, Shannon L Puhalla, Christie J Hilton, Chau T Dang, Henry Leonidas Gómez, Svetislava J Vukelja, Alan P Lyss, Devchand Paul, Adam M Brufsky, Linda H Colangelo, Sandra M Swain, Eleftherios P P Mamounas, Norman Wolmark
Long-Term Follow-Up of the Anthracyclines in Early Breast Cancer Trials (USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 [NRG Oncology]). Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Aditya Bardia, Hope S Rugo, Sara M Tolaney, Delphine Loirat, Kevin Punie, Mafalda Oliveira, Adam M Brufsky, Kevin M Kalinsky, Javier Cortes, Joyce O' Shaughnessy, Véronique Diéras, Lisa Anne Carey, Luca Gianni, Martine J Piccart, Sibylle Loibl, Oh Kyu Yoon, Yang Pan, Scott Hofsess, See-Chun Phan, Sara Alsterlind Hurvitz
Final Results From the Randomized Phase III ASCENT Clinical Trial in Metastatic Triple-Negative Breast Cancer and Association of Outcomes by Human Epidermal Growth Factor Receptor 2 and Trophoblast Cell Surface Antigen 2 Expression. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (15) (2024)
Eleftherios P P Mamounas, Hanna Bandos, Priya Rastogi, Yi Zhang, Kai Treuner, Peter C Lucas, Charles E Geyer, Louis Fehrenbacher, Stephen K L Chia, Adam M Brufsky, Janice M Walshe, Gamini S Soori, Shaker R Dakhil, Soonmyung Paik, Sandra M Swain, Dennis C Sgroi, Catherine A Schnabel, Norman Wolmark
Breast Cancer Index and Prediction of Extended Aromatase Inhibitor Therapy Benefit in Hormone Receptor-Positive Breast Cancer from the NRG Oncology/NSABP B-42 Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (9) (2024)
Priya Rastogi, Hanna Bandos, Peter C Lucas, Laura van 't Veer, Jia-Perng J Wei, Charles E Geyer, Louis Fehrenbacher, Stephen K L Chia, Adam M Brufsky, Janice M Walshe, Gamini S Soori, Shaker R Dakhil, Soonmyung Paik, Sandra M Swain, Andrea R Menicucci, M William Audeh, Norman Wolmark, Eleftherios P P Mamounas
Utility of the 70-Gene MammaPrint Assay for Prediction of Benefit From Extended Letrozole Therapy in the NRG Oncology/NSABP B-42 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Eleftherios P P Mamounas, Hanna Bandos, Priya Rastogi, Yi Zhang, Kai Treuner, Peter C Lucas, Charles E Geyer, Louis Fehrenbacher, Stephen K L Chia, Adam M Brufsky, Janice M Walshe, Gamini S Soori, Shaker R Dakhil, Soonmyung Paik, Sandra M Swain, Dennis C Sgroi, Catherine A Schnabel, Norman Wolmark
Breast Cancer Index and Prediction of Extended Aromatase Inhibitor Therapy Benefit in Hormone Receptor-Positive Breast Cancer from the NRG Oncology/NSABP B-42 Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (9) (2024)
Aditya Bardia, Hope S Rugo, Sara M Tolaney, Delphine Loirat, Kevin Punie, Mafalda Oliveira, Adam M Brufsky, Kevin M Kalinsky, Javier Cortes, Joyce O' Shaughnessy, Véronique Diéras, Lisa Anne Carey, Luca Gianni, Martine J Piccart, Sibylle Loibl, Oh Kyu Yoon, Yang Pan, Scott Hofsess, See-Chun Phan, Sara Alsterlind Hurvitz
Final Results From the Randomized Phase III ASCENT Clinical Trial in Metastatic Triple-Negative Breast Cancer and Association of Outcomes by Human Epidermal Growth Factor Receptor 2 and Trophoblast Cell Surface Antigen 2 Expression. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (15) (2024)
Margarita L Zuley, Jonathan C Silverstein, Durwin Logue, Richard S Morgan, Rohit Bhargava, Priscilla F McAuliffe, Adam M Brufsky, Andriy I Bandos, Robert M Nishikawa
Organizational Breast Cancer Data Mart: A Solution for Assessing Outcomes of Imaging and Treatment. JCO clinical cancer informatics 8 (2024)
Margarita L Zuley, Jonathan C Silverstein, Durwin Logue, Richard S Morgan, Rohit Bhargava, Priscilla F McAuliffe, Adam M Brufsky, Andriy I Bandos, Robert M Nishikawa
Organizational Breast Cancer Data Mart: A Solution for Assessing Outcomes of Imaging and Treatment. JCO clinical cancer informatics 8 (2024)
Charles E Geyer, Joanne L Blum, Greg Yothers, Lina Asmar, Patrick J Flynn, Nicholas J Robert, Judith O Hopkins, Joyce A O'Shaughnessy, Priya Rastogi, Shannon L Puhalla, Christie J Hilton, Chau T Dang, Henry Leonidas Gómez, Svetislava J Vukelja, Alan P Lyss, Devchand Paul, Adam M Brufsky, Linda H Colangelo, Sandra M Swain, Eleftherios P P Mamounas, Norman Wolmark
Long-Term Follow-Up of the Anthracyclines in Early Breast Cancer Trials (USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 [NRG Oncology]). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (12) (2024)
Evanthia T Roussos Torres, Won Jin Ho, Ludmila Danilova, Joseph A Tandurella, James Leatherman, Christine Rafie, Chenguang Wang, Adam M Brufsky, Patricia M LoRusso, Vincent Chung, Yuan Yuan, Melinda Downs, Ashley O'Connor, Sarah M Shin, Alexei Hernandez, Elizabeth L Engle, Richard Piekarz, Howard Streicher, Zahra Talebi, Michelle A Rudek, Qingfeng Zhu, Robert A Anders, Ashley Cimino-Mathews, Elana J Fertig, Elizabeth D Thompson, Vered Stearns, Caitriona Cahir
Entinostat, nivolumab and ipilimumab for women with advanced HER2-negative breast cancer: a phase Ib trial. Nature cancer (2024)
Adam M Brufsky, Xianchen Liu, Benjamin Li, Lynn McRoy, Connie Chen, Rachel M Layman, Hope S Rugo
Palbociclib Combined with an Aromatase Inhibitor in Patients with Breast Cancer with Lung or Liver Metastases in US Clinical Practice. Cancers 15 (21) (2023)
Adam M Brufsky, Christopher Gallagher
P-REALITY X: A Real-World Analysis of Palbociclib Plus an Aromatase Inhibitor in HR+/HER2- Metastatic Breast Cancer-A Podcast. Targeted oncology 18 (3) (2023)
Adam M Brufsky, Christopher Gallagher
P-REALITY X: A Real-World Analysis of Palbociclib Plus an Aromatase Inhibitor in HR+/HER2- Metastatic Breast Cancer-A Podcast. Targeted oncology 18 (3) (2023)
Jamie O Brett, Taronish D Dubash, Gabriela N Johnson, Andrzej Niemierko, Veronica Mariotti, Leslie S L Kim, Jing Xi, Apurva Pandey, Siobhan Dunne, Azadeh Nasrazadani, Maxwell R Lloyd, Avinash Kambadakone, Laura M Spring, Douglas S Micalizzi, Maristela L Onozato, Dante Che, Utthara Nayar, Adam M Brufsky, Kevin M Kalinsky, Cynthia X Ma, Joyce O'Shaughnessy, Hyo S Han, Anthony J Iafrate, Lianne Y Ryan, Dejan Juric, Beverly Moy, Leif W Ellisen, Shyamala Maheswaran, Nikhil Wagle, Daniel A Haber, Aditya Bardia, Seth A Wander
A Gene Panel Associated With Abemaciclib Utility in ESR1 -Mutated Breast Cancer After Prior Cyclin-Dependent Kinase 4/6-Inhibitor Progression. JCO precision oncology 7 (2023)
Adam M Brufsky, Christopher Gallagher
P-REALITY X: A Real-World Analysis of Palbociclib Plus an Aromatase Inhibitor in HR+/HER2- Metastatic Breast Cancer-A Podcast. Targeted oncology 18 (3) (2023)
Adam M Brufsky, Christopher Gallagher
P-REALITY X: A Real-World Analysis of Palbociclib Plus an Aromatase Inhibitor in HR+/HER2- Metastatic Breast Cancer-A Podcast. Targeted oncology (2023)
Jamie O Brett, Taronish D Dubash, Gabriela N Johnson, Andrzej Niemierko, Veronica Mariotti, Leslie S L Kim, Jing Xi, Apurva Pandey, Siobhan Dunne, Azadeh Nasrazadani, Maxwell R Lloyd, Avinash Kambadakone, Laura M Spring, Douglas S Micalizzi, Maristela L Onozato, Dante Che, Utthara Nayar, Adam M Brufsky, Kevin M Kalinsky, Cynthia X Ma, Joyce O'Shaughnessy, Hyo S Han, Anthony J Iafrate, Lianne Y Ryan, Dejan Juric, Beverly Moy, Leif W Ellisen, Shyamala Maheswaran, Nikhil Wagle, Daniel A Haber, Aditya Bardia, Seth A Wander
A Gene Panel Associated With Abemaciclib Utility in ESR1 -Mutated Breast Cancer After Prior Cyclin-Dependent Kinase 4/6-Inhibitor Progression. JCO precision oncology 7 (2023)
Juan Luis Gomez Marti, Azadeh Nasrazadani, Ying Ding, Daniel Normolle, Adam M Brufsky
Twenty-Year Follow-Up of a Phase II Trial of Taxotere/Carboplatin/Herceptin in Patients With Metastatic HER2-Positive Breast Cancer. The oncologist (2023)
Adam M Brufsky, Christopher Gallagher
P-REALITY X: A Real-World Analysis of Palbociclib Plus an Aromatase Inhibitor in HR+/HER2- Metastatic Breast Cancer-A Podcast. Targeted oncology 18 (3) (2023)
Hope S Rugo, Xianchen Liu, Benjamin Li, Lynn McRoy, Connie Chen, Rachel M Layman, Adam M Brufsky
Real-World Effectiveness of Palbociclib Plus Aromatase Inhibitors in African American Patients With Metastatic Breast Cancer. The oncologist (2023)
Susrutha Puthanmadhom Narayanan, Dianxu Ren, Steffi Oesterreich, Adrian V Lee, Margaret Q Rosenzweig, Adam M Brufsky
Effects of socioeconomic status and race on survival and treatment in metastatic breast cancer. NPJ breast cancer 9 (1) (2023)
Hope S Rugo, Adam M Brufsky, Xianchen Liu, Benjamin Li, Lynn McRoy, Connie Chen, Rachel M Layman, Massimo Cristofanilli, Mylin A Torres, Curigliano Giuseppe, Richard S Finn, Angela DeMichele
Real-world study of overall survival with palbociclib plus aromatase inhibitor in HR+/HER2- metastatic breast cancer. NPJ breast cancer 8 (1) (2022)
Foluso O Ademuyiwa, Feng Gao, Cherease R Street, Ina Chen, Donald W Northfelt, Robert Wesolowski, Mili Arora, Adam M Brufsky, E Claire Dees, Cesar A Santa-Maria, Caitriona Cahir, Jeremy Force, Alvaro Moreno-Aspitia, John M Herndon, Madelyn Carmody, Sherri R Davies, Sarah Larson, Kathleen L Pfaff, Stephanie M Jones, Jason L Weirather, Anita Giobbie-Hurder, Scott J Rodig, Zheng Liu, Ian S Hagemann, Elad Sharon, William E Gillanders
A randomized phase 2 study of neoadjuvant carboplatin and paclitaxel with or without atezolizumab in triple negative breast cancer (TNBC) - NCI 10013. NPJ breast cancer 8 (1) (2022)
Elrashdy Mustafa Redwan, Fatma Elrashdy, Alaa A A Aljabali, Wagner Baetas-da-Cruz, Debmalya Barh, Adam M Brufsky, Sk Sarif Hassan, Kenneth Lundstrom, Ãngel Serrano-Aroca, Kazuo Takayama, Murtaza M Tambuwala, Bruce D Uhal, Vladimir N Uversky
Would New SARS-CoV-2 Variants Change the War against COVID-19? Epidemiolgia (Basel, Switzerland) 3 (2) (2022)
Juan Luis Gomez Marti, Adam M Brufsky, Alan Wells, Xia Jiang
Machine Learning to Discern Interactive Clusters of Risk Factors for Late Recurrence of Metastatic Breast Cancer. Cancers 14 (1) (2022)
Foluso O Ademuyiwa, Feng Gao, Cherease R Street, Ina Chen, Donald W Northfelt, Robert Wesolowski, Mili Arora, Adam M Brufsky, E Claire Dees, Cesar A Santa-Maria, Caitriona Cahir, Jeremy Force, Alvaro Moreno-Aspitia, John M Herndon, Madelyn Carmody, Sherri R Davies, Sarah Larson, Kathleen L Pfaff, Stephanie M Jones, Jason L Weirather, Anita Giobbie-Hurder, Scott J Rodig, Zheng Liu, Ian S Hagemann, Elad Sharon, William E Gillanders
A randomized phase 2 study of neoadjuvant carboplatin and paclitaxel with or without atezolizumab in triple negative breast cancer (TNBC) - NCI 10013. NPJ breast cancer 8 (1) (2022)
Foluso O Ademuyiwa, Feng Gao, Cherease R Street, Ina Chen, Donald W Northfelt, Robert Wesolowski, Mili Arora, Adam M Brufsky, E Claire Dees, Cesar A Santa-Maria, Caitriona Cahir, Jeremy Force, Alvaro Moreno-Aspitia, John M Herndon, Madelyn Carmody, Sherri R Davies, Sarah Larson, Kathleen L Pfaff, Stephanie M Jones, Jason L Weirather, Anita Giobbie-Hurder, Scott J Rodig, Zheng Liu, Ian S Hagemann, Elad Sharon, William E Gillanders
A randomized phase 2 study of neoadjuvant carboplatin and paclitaxel with or without atezolizumab in triple negative breast cancer (TNBC) - NCI 10013. NPJ breast cancer 8 (1) (2022)
Sk Sarif Hassan, Vaishnavi Kodakandla, Elrashdy Mustafa Redwan, Kenneth Lundstrom, Pabitra Pal Choudhury, Tarek Mohamed Abd El-Aziz, Kazuo Takayama, Ramesh Kandimalla, Amos Lal, Ángel Serrano-Aroca, Gajendra Kumar Azad, Alaa A A Aljabali, Giorgio Palù, Gaurav Chauhan, Parise Adadi, Murtaza Tambuwala, Adam M Brufsky, Wagner Baetas-da-Cruz, Debmalya Barh, Vasco Ariston de Carvalho Azevedo, Nikolas G Bazan, Bruno Silva Andrade, Raner José Santana Silva, Vladimir N Uversky
An issue of concern: unique truncated ORF8 protein variants of SARS-CoV-2. PeerJ 10 (2022)
Parvin F Peddi, Peter Andreas Fasching, Duan Liu, Emmanuel Quinaux, Nicholas J Robert, Vicente Valero, John Crown, Carla I Falkson, Adam M Brufsky, Julie M Cunningham, Richard M Weinshilboum, Tadeusz Pienkowski, Wolfgang Eiermann, Miguel Martin, Valerie Bee, Xiaoyan Wang, Liewei Wang, Eric H Yang, Dennis J Slamon, Sara A Hurvitz
Genetic Polymorphisms and Correlation with Treatment-Induced Cardiotoxicity and Prognosis in Patients with Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (9) (2022)
Jeanna Wallenta Law, Debanjali Mitra, Henry G Kaplan, Tamuno Alfred, Adam M Brufsky, Birol Emir, Haley McCracken, Xianchen Liu, Ronda G Broome, Chenan Zhang, Caroline DiCristo, Connie Chen
Real-World Treatment Patterns and Clinical Effectiveness of Palbociclib Plus an Aromatase Inhibitor as First-Line Therapy in Advanced/Metastatic Breast Cancer: Analysis from the US Syapse Learning Health Network. Current oncology (Toronto, Ont.) 29 (2) (2022)
Foluso O Ademuyiwa, Feng Gao, Cherease R Street, Ina Chen, Donald W Northfelt, Robert Wesolowski, Mili Arora, Adam M Brufsky, E Claire Dees, Cesar A Santa-Maria, Caitriona Cahir, Jeremy Force, Alvaro Moreno-Aspitia, John M Herndon, Madelyn Carmody, Sherri R Davies, Sarah Larson, Kathleen L Pfaff, Stephanie M Jones, Jason L Weirather, Anita Giobbie-Hurder, Scott J Rodig, Zheng Liu, Ian S Hagemann, Elad Sharon, William E Gillanders
A randomized phase 2 study of neoadjuvant carboplatin and paclitaxel with or without atezolizumab in triple negative breast cancer (TNBC) - NCI 10013. NPJ breast cancer 8 (1) (2022)
Pooja Srivastava, Tiannan Wang, Beth Z Clark, Jing Yu, Jeffrey L Fine, Tatiana M Villatoro, Gloria J Carter, Adam M Brufsky, Vikram C Gorantla, Shannon L Huggins-Puhalla, Leisha A Emens, Thais Basili de Oliveira, Edaise M Da Silva, Jorge Sergio Reis-Filho, Rohit Bhargava
Clinical-pathologic characteristics and response to neoadjuvant chemotherapy in triple-negative low Ki-67 proliferation (TNLP) breast cancers. NPJ breast cancer 8 (1) (2022)
Angela M DeMichele, Massimo Cristofanilli, Adam M Brufsky, Xianchen Liu, Jack Mardekian, Lynn McRoy, Rachel M Layman, Birol Emir, Mylin A Torres, Hope S Rugo, Richard S Finn
Comparative effectiveness of first-line palbociclib plus letrozole versus letrozole alone for HR+/HER2- metastatic breast cancer in US real-world clinical practice. Breast cancer research : BCR 23 (1) (2021)
Kenneth Lundstrom, Debmalya Barh, Bruce D Uhal, Kazuo Takayama, Alaa A A Aljabali, Tarek Mohamed Abd El-Aziz, Amos Lal, Elrashdy Mustafa Redwan, Parise Adadi, Gaurav Chauhan, Samendra P Sherchan, Gajendra Kumar Azad, Nima Rezaei, Ãngel Serrano-Aroca, Nicolas G Bazan, Sk Sarif Hassan, Pritam Kumar Panda, Pabitra Pal Choudhury, Damiano Pizzol, Ramesh Kandimalla, Wagner Baetas-da-Cruz, Yogendra Kumar Mishra, Giorgio Palu, Adam M Brufsky, Murtaza M Tambuwala, Vladimir N Uversky
COVID-19 Vaccines and Thrombosis-Roadblock or Dead-End Street? Biomolecules 11 (7) (2021)
Murat Seyran, Sk Sarif Hassan, Vladimir N Uversky, Pabitra Pal Choudhury, Bruce D Uhal, Kenneth Lundstrom, Diksha Attrish, Nima Rezaei, Alaa A A Aljabali, Shinjini Ghosh, Damiano Pizzol, Parise Adadi, Tarek Mohamed Abd El-Aziz, Ramesh Kandimalla, Murtaza M Tambuwala, Amos Lal, Gajendra Kumar Azad, Samendra P Sherchan, Wagner Baetas-da-Cruz, Giorgio Palù, Adam M Brufsky
Urgent Need for Field Surveys of Coronaviruses in Southeast Asia to Understand the SARS-CoV-2 Phylogeny and Risk Assessment for Future Outbreaks. Biomolecules 11 (3) (2021)
Alexander H G Paterson, Peter C Lucas, Stewart J Anderson, Eleftherios P Mamounas, Adam M Brufsky, Luis Baez-Diaz, Karen M King, Thomas Lad, André Robidoux, Melanie Finnigan, Miguel Sampayo, Juan Carlos Tercero, Joël Jean Mairet, Antonio C Wolff, Louis Fehrenbacher, Norman Wolmark, Roger R Gomis
MAF Amplification and Adjuvant Clodronate Outcomes in Early-Stage Breast Cancer in NSABP B-34 and Potential Impact on Clinical Practice. JNCI cancer spectrum 5 (4) (2021)
Rohit Bhargava, Nicole N Esposito, Siobhan M OʹConnor, Zaibo Li, Bradley M Turner, Ioana Moisini, Aditi Ranade, Ronald P Harris, Dylan V Miller, Xiaoxian Li, Harrison Moosavi, Beth Z Clark, Adam M Brufsky, David J Dabbs
Magee Equations™ and response to neoadjuvant chemotherapy in ER+/HER2-negative breast cancer: a multi-institutional study. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 34 (1) (2020)
Sk Sarif Hassan, Shinjini Ghosh, Diksha Attrish, Pabitra Pal Choudhury, Alaa A A Aljabali, Bruce D Uhal, Kenneth Lundstrom, Nima Rezaei, Vladimir N Uversky, Murat Seyran, Damiano Pizzol, Parise Adadi, Antonio Soares, Tarek Mohamed Abd El-Aziz, Ramesh Kandimalla, Murtaza M Tambuwala, Gajendra Kumar Azad, Samendra P Sherchan, Wagner Baetas-da-Cruz, Kazuo Takayama, Ãngel Serrano-Aroca, Gaurav Chauhan, Giorgio Palu, Adam M Brufsky
Possible Transmission Flow of SARS-CoV-2 Based on ACE2 Features. Molecules (Basel, Switzerland) 25 (24) (2020)
Atilla Soran, Serdar Ozbas, Lutfi Dogan, Efe Sezgin, Vahit Özmen, Sushil Beriwal, Adam M Brufsky
Loco-Regional Treatment for Intact Primary Tumor in Patient with De Novo Metastatic Breast Cancer; Comments and Concerns of ECOG-ACRIN 2108 Trial. European journal of breast health 16 (3) (2020)
Adam M Brufsky, Michael T Lotze
Ratcheting down the virulence of SARS-CoV-2 in the COVID-19 pandemic. Journal of medical virology 92 (11) (2020)
Kenneth Lundstrom, Murat Seyran, Damiano Pizzol, Parise Adadi, Tarek Mohamed Abd El-Aziz, Sk Sarif Hassan, Antonio Soares, Ramesh Kandimalla, Murtaza M Tambuwala, Alaa A A Aljabali, Gajendra Kumar Azad, Pabitra Pal Choudhury, Vladimir N Uversky, Samendra P Sherchan, Bruce D Uhal, Nima Rezaei, Adam M Brufsky
Viewpoint: Origin of SARS-CoV-2. Viruses 12 (11) (2020)
Adam M Brufsky
Hyperglycemia, hydroxychloroquine, and the COVID-19 pandemic. Journal of medical virology 92 (7) (2020)
Adam M Brufsky
Distinct viral clades of SARS-CoV-2: Implications for modeling of viral spread. Journal of medical virology 92 (9) (2020)
Adam M Brufsky, Michael T Lotze
DC/L-SIGNs of hope in the COVID-19 pandemic. Journal of medical virology 92 (9) (2020)
Joseph Brewer, Juan Luis Gomez Marti, Adam M Brufsky
Potential interventions for SARS-CoV-2 infections: Zinc showing promise. Journal of medical virology 93 (3) (2020)
Nadine M Tung, Mark E Robson, Steffen Ventz, Cesar A Santa-Maria, Rita Nanda, P Kelly Marcom, Payal Deepak Shah, Tarah J Ballinger, Eddy Shih-Hsin Yang, Shaveta Vinayak, Michelle E Melisko, Adam M Brufsky, Michelle DeMeo, Colby Jenkins, Susan M Domchek, Alan D' Andrea, Nancy U Lin, Melissa E Hughes, Lisa Anne Carey, Nikhil Wagle, Gerburg M Wulf, Ian E Krop, Antonio C Wolff, Eric P Winer, Judy E Garber
TBCRC 048: Phase II Study of Olaparib for Metastatic Breast Cancer and Mutations in Homologous Recombination-Related Genes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 38 (36) (2020)
Murat Seyran, Damiano Pizzol, Parise Adadi, Tarek Mohamed Abd El-Aziz, Sk Sarif Hassan, Antonio Soares, Ramesh Kandimalla, Kenneth Lundstrom, Murtaza M Tambuwala, Alaa A A Aljabali, Amos Lal, Gajendra K Azad, Pabitra P Choudhury, Vladimir N Uversky, Samendra P Sherchan, Bruce D Uhal, Nima Rezaei, Adam M Brufsky
Questions concerning the proximal origin of SARS-CoV-2. Journal of medical virology 93 (3) (2020)
Adam M Brufsky, Juan Luis Gomez Marti, Azadeh Nasrazadani, Michael T Lotze
Boning up: amino-bisphophonates as immunostimulants and endosomal disruptors of dendritic cell in SARS-CoV-2 infection. Journal of translational medicine 18 (1) (2020)
Stephen M Smith, Avinash Boppana, Julie A Traupman, Enrique Unson, Daniel A Maddock, Kathy Chao, David P Dobesh, Adam M Brufsky, Ruth I Connor
Impaired glucose metabolism in patients with diabetes, prediabetes, and obesity is associated with severe COVID-19. Journal of medical virology 93 (1) (2020)